Standard BioTools Inc. (FRA:FLB)
Germany
· Delayed Price · Currency is EUR 1.230
+0.020 (1.65%)
At close: Dec 5, 2025
Standard BioTools Revenue
Standard BioTools had revenue of $19.55M USD in the quarter ending September 30, 2025, a decrease of -11.47%. This brings the company's revenue in the last twelve months to $169.74M, up 79.77% year-over-year. In the year 2024, Standard BioTools had annual revenue of $174.43M with 64.03% growth.
Revenue (ttm)
$169.74M
Revenue Growth
+79.77%
P/S Ratio
3.27
Revenue / Employee
$207.50K
Employees
818
Market Cap
472.72M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 174.43M | 68.09M | 64.03% |
| Dec 31, 2023 | 106.34M | 8.39M | 8.57% |
| Dec 31, 2022 | 97.95M | -32.63M | -24.99% |
| Dec 31, 2021 | 130.58M | -7.56M | -5.47% |
| Dec 31, 2020 | 138.14M | 20.90M | 17.83% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Rheinmetall AG | 11.00B |
| Deutsche Bank Aktiengesellschaft | 29.86B |